[1]
Tam, L.T.K. and Hoa, N.T.T. 2025. Comment on primary effectiveness of rituximab plus chemotherapy in treating CD 20 + non hodgkin lymphoma. Journal of Clinical Medicine Hue Central Hospital. 5, 17 (Feb. 2025), 191–195. DOI:https://doi.org/10.38103.17.33.